Pharma and Biotech
Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
30-Jun-23 | Interim | n/a | (0.46) | (0.12)p | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | n/a | (0.83) | n/a | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (0.01) | (2.80)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (3.96) | (2.40)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (0.96) | (0.30)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 1.65p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 3.20 |
52 Week Low | 1.61 |
Volume | 226,509 |
Shares Issued | 396.39m |
Market Cap | £6.54m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:57 | 18,605 @ 1.61p |
13:56 | 5,500 @ 1.67p |
13:51 | 30,000 @ 1.67p |
12:40 | 5,000 @ 1.61p |
12:40 | 4,569 @ 1.67p |
Finance Director | Nigel Ronald Lee |
You are here: research